Cancer Virus Protein Needed for Infection
Posted on: Friday, 31 March 2006, 21:25 CST
(RedOrbit) New research by scientists with The Ohio State University Cancer Program and OSU College of Veterinary Medicine shows that a protein called p13 is needed for the cancer-causing virus human T lymphotropic virus type 1 (HTLV-1) to successfully infect and reproduce within the body.
p13 is a type of 'accessory' protein previously thought to be unimportant for HTLV-1 survival. According to Michael Lairmore, professor and Chair of Veterinary Biosciences and a member of the OSU Comprehensive Cancer Center, "it is important to understand the function of these accessory molecules so we know if they should be incorporated into vaccines or targeted by new drugs as a way to prevent infection."
HTLV-1, which is spread by sexual activity, infected blood or breast milk, infects 15 to 20 million people worldwide, about 5% of whom develop adult T cell leukemia or lymphoma (ATLL.)
"These findings should help us begin to learn whether this viral protein influences cell survival, perhaps by extending the life of the cell," says Lairmore. The research will be published in the April 1 issue of the Journal of Virology.
By Karen Ventii of RedOrbit from Wire reports
Related Articles
- Gene Regulates Cancer Stem Cells in Brain Cancer
- Scientists Discover Bladder Cancer Stem Cell
- Controversial Cancer Stem Cells Offer New Outlook For Treatment
- Scientists Develop Model That Could Help Identify Cancer Stem Cells
- Finding Breast Cancer Stem Cells In Mice
- Cancer Stem Cells Generated By Cancer Outgrowth
- Virus Targets and Kills Apparent Cancer Stem Cells in Neuroblastoma
- ImmunoCellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem Cell Vaccine in Preclinical Model
- Stanford Researchers Create Cancer Stem Cells
- New Report Examines Emerging Therapeutic, Diagnostic and Market Opportunities in the Area of Cancer Stem Cell Research
User Comments (0)

RSS Feeds